Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 5/7/2025Roche's Columvi Wins Expanded Approval in China for 2L+ DLBCL
  • 5/7/2025Novo Nordisk Sees Surge in China on Wegovy Launch, GLP-1 Momentum
  • 5/7/2025Everest Medicines Announces NMPA Full Approval of NEFECON
  • 5/7/2025Early Clinical Data from China Show Promise for In Vivo CAR-T Therapie...
  • 5/7/2025AccurEdit's In Vivo Gene-Editing Drug ART001 Shows Sustained Efficacy ...
  • 5/7/2025Innovent Presents Positive Phase 2 Data for First-in-Class Bispecific ...
  • 5/6/2025Immunochina’s IM96 CAR-T Cell Therapy Wins FDA IND Clearance
  • 5/6/2025China Approves Six Novel Drugs in April 2025, Marking Significant Adva...
  • 5/6/2025Kintor Reports Superior Hair Regrowth Results for KX-826 and Minoxidil...
  • 5/6/2025CStone Unveils Promising Preclinical Data for Trispecific Antibody CS2...
  • 5/6/2025China Seeks Feedbacks on Draft Guideline for Risk Management Plan Duri...
  • 5/6/2025China Seeks Feedbacks on ICH Q1 Stability Testing Guideline Draft
  • 5/6/2025China Announces Ambitious Plan to Optimize Primary Healthcare System b...
  • 5/2/2025Recent Executive Moves
  • 5/1/2025D3 Bio Showcases Promising Next-Gen KRAS G12C Inhibitor at AACR and in...
  • 5/1/2025China Accelerates Investment in Africa's Burgeoning Pharma Sector
  • 5/1/2025CSL Reviews Potential China Tariff Relief for U.S.-Produced Albumin
  • 5/1/2025AstraZeneca Faces Escalating Legal Challenges in China Over Drug Impor...
  • 4/30/2025Sandoz and Henlius Collaborate to Broaden Oncology Treatment Options
  • 4/30/2025Escugen and ConjugateBio Announce Exclusive Option Agreement for EZWi-...
  • 4/30/2025BeiGene Secures Key Patent Victory in Brukinsa Dispute with AbbVie's P...
  • 4/29/2025AstraZeneca's China Business Recovers in Q1 2025 Amid Easing Regulator...
  • 4/29/2025China Orders Drugmakers, Hospitals to Study US Import Replacements
  • 4/29/2025State Council Approves Draft Medical Security Law, Strengthening Fund ...
  • 4/29/202553 Original Research Drugs Approved in China in Early 2025
  • 4/29/2025BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China
  • 4/29/2025ConjugateBio Secures Exclusive Option for Escugen's EZWi-Fit® Platfor...
  • 4/29/2025Europe Emerges as Key Partner for China Pharma Deals Amid US Market Sh...
  • 4/29/2025AmCham China Reports Chinese Tariff Exemptions for Some Pharma Firms A...
  • 4/29/2025Innovent Announces NMPA Approval of Limertinib
  • Page:15/54 Total number of articles:1609: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group